← Back to Search

Behavioral Intervention

COAST-enhanced CBTI for Chronic Insomnia

N/A
Recruiting
Led By Anne Germain
Research Sponsored by Noctem, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month follow up
Awards & highlights

Study Summary

This trial aims to see if using an online platform for Cognitive Behavioral Treatment of Insomnia is as effective as the standard care for insomnia in military facilities. They will compare the two methods in terms of improving

Who is the study for?
This trial is for active duty service members aged 18 or older who have chronic insomnia and are cleared for Cognitive Behavioral Treatment of Insomnia (CBTI). They must not have any serious health issues that could affect their safety, and if they're taking sleep meds, the dose must be stable for at least 4 weeks. Participants also need a recent smartphone.Check my eligibility
What is being tested?
The study compares traditional insomnia care at military facilities with a new digital platform called COAST-enhanced CBTI to see which is better for treating insomnia, depression, anxiety symptoms, and patient satisfaction.See study design
What are the potential side effects?
Since this trial involves cognitive behavioral therapy delivered digitally rather than medication, side effects may include discomfort from discussing personal issues or using technology but typically do not involve physical side effects.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Insomnia Care
Insomnia Severity
Satisfaction with Insomnia Care
+2 more

Trial Design

2Treatment groups
Active Control
Group I: COAST-enhanced CBTIActive Control1 Intervention
Patients randomized to COAST will receive CBTI via the COAST platform, with the assistance of a licensed clinician via NOCTEM's digital sleep hub. Participants will utilize the COAST patient app on their smartphone for engagement in insomnia treatment and receipt of clinician's recommendations. COAST clinicians will utilize the COAST web-based portal for adherence monitoring, progress review, and for providing personalized insomnia treatment recommendations.
Group II: Military Treatment Facility Insomnia Care As UsualActive Control1 Intervention
Patients randomized to the ICAU arm will receive insomnia care as usual by a certified clinician at their respective site, according to current referral and treatment practices.

Find a Location

Who is running the clinical trial?

Noctem, LLCLead Sponsor
1 Previous Clinical Trials
17 Total Patients Enrolled
Anne GermainPrincipal InvestigatorNoctem, LLC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current cumulative count of individuals participating in this clinical investigation?

"Indeed, the details available on clinicaltrials.gov confirm that this trial is currently enrolling participants. The trial was first listed on August 16th, 2023 and its most recent update was made on March 19th, 2024. It aims to recruit a total of 188 patients at one designated site."

Answered by AI

Are individuals currently able to apply and participate in this ongoing medical trial?

"Indeed, the details on clinicaltrials.gov confirm that this current research study is actively seeking eligible individuals. The trial was initially published on August 16th, 2023 and last revised on March 19th, 2024. Recruitment aims to enlist a total of 188 participants across one designated site."

Answered by AI
~88 spots leftby Dec 2024